Five of the world’s biggest drugs companies have agreed to slash the price of
their anti-HIV drugs in developing countries by 85 per cent following sustained
pressure from health agencies, Third World governments and patient groups
(New Å®ÉúСÊÓƵ, 29 April, p 14).
One of the companies, Glaxo Wellcome, is
cutting the price of triple drug therapy from $16 to $2 a day. But
pressure groups have warned that even at these prices, poverty and a lack of
health infrastructure in poor countries will mean the benefits are limited.
To continue reading, today with our introductory offers
Advertisement
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
How I used psychology to come back from the worst year of my life
6
The distant world that is our best hope of finding alien life
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
Epic dreaming is leaving people exhausted and distressed
9
Extreme heat hampers children’s early learning
10
CAR T-cell therapy bolstered by stiffening up cancer cells first
